Latest News - Fillers & Injectables

Thursday, October 11, 2018 | Personnel/Company News, Phase 3/4 Trials, PracticalDermatology.com, Research and Publications, Galderma

Galderma Announces the Start of Six New Aesthetic Studies

Galderma Laboratories, L.P. is initiating six new Phase III and IV U.S. aesthetic clinical trials. The six newly initiated studies include three pivotal trials evaluating XpresHAn Technology p…

Read the full story

Tuesday, October 09, 2018 | PracticalDermatology.com, Research and Publications

BAAPS Calls for Brazilian Butt Lift Ban

Due to the serious risks associated with the Brazilian butt lift, the British Association of Aesthetic Plastic Surgeons (BAAPS) is calling for a ban on the popular procedure until more data can be col…

Read the full story

Wednesday, October 03, 2018 | PracticalDermatology.com, Product Launches and Updates, Allergan

Introducing Juvéderm It, Allergan’s Newest Ad Campaign

Allergan plc is rolling out a new Juvéderm advertising campaign that aims to make this family of fillers a household name. Comprising a modernized logo, a bright, poppy color scheme, an edgy…

Read the full story

Thursday, September 27, 2018 | PracticalDermatology.com, PracticalDermatology.com, Research and Publications, RealSelf

RealSelf: One in Three U.S. Adults are Considering Nips/Tucks

One in three adults (37 percent) in the U.S. are considering at least one cosmetic treatment in the next 12 months, with significantly more considering nonsurgical procedures (34 percent) than surgica…

Read the full story

Wednesday, September 26, 2018 | PracticalDermatology.com, PracticalDermatology.com

ASPS Members Identify Key Plastic Surgery Trends

Breast augmentation, tummy tucks and liposuction will be the three most popular plastic surgery procedures in 2019, plastic surgeons predict. With regard to minimally invasive procedures, Botox sti…

Read the full story

Tuesday, September 25, 2018 | PracticalDermatology.com, PracticalDermatology.com, Product Launches and Updates, Galderma

Galderma Launches "Face Your Hands" Campaign with Celebrity Manicurist

Galderma Laboratories, L.P.,’s Restylane® Lyft is partnering with celebrity manicurist Deborah Lippmann for the "Face Your Hands" campaign, which aims to educate women on the steps…

Read the full story

Monday, September 24, 2018 | Healthcare Trends, Personnel/Company News, PracticalDermatology.com, PracticalDermatology.com, Galderma

Nestle to Explore Strategic Options for Skin Health Division

...After further analysis and consideration, the Board has come to the conclusion that the future growth opportunities of Nestlé Skin Health lie increasingly outside the Group’s strategic…

Read the full story

Wednesday, September 19, 2018 | Acquisitions and Mergers, PracticalDermatology.com, Product Launches and Updates, Allergan , Bonti

Special Report: Behind Allergan’s and Bonti’s Headline-Making Deal

The race was on. After years of dormancy in the neuromodulator category, at least three novel toxins -- Evolus’ DWP-450, Revance’s daxibotulinumtoxinA, and Bonti’s EB-001 -- were co…

Read the full story

Monday, September 17, 2018 | PracticalDermatology.com, PracticalDermatology.com, PracticalDermatology.com, PracticalDermatology.com, Research and Publications, American Society for Dermatologic Surgery

ASDS 2018 Survey: Close to 70 percent of Consumers Thinking About Cosmetic Treatments

Almost 70 percent of consumers are considering a cosmetic treatment, and more than half would prefer to pay more up front to lower their annual skin care costs, according to the 2018 America…

Read the full story

Monday, September 17, 2018 | PracticalDermatology.com, Allergan

Allergan Shares Results of Higher Dose Botox Cosmetic for the Treatment Glabellar Lines

Allergan plc  clinical study results of higher doses of Botox Cosmetic compared to Botox Cosmetic 20 unit dose at week 24 in patients with moderate to severe glabellar lines. Allergan co…

Read the full story

Friday, September 14, 2018 | Acquisitions and Mergers, PracticalDermatology.com, Allergan , Bonti

Allergan Acquires Bonti for $195M

Allergan acquired Bonti, Inc., a privately held clinical-stage biotechnology company focused on the development and commercialization of novel, fast-acting neurotoxin programs for aesthetic and therap…

Read the full story

Wednesday, September 12, 2018 | Healthcare Trends, Personnel/Company News, PracticalDermatology.com, PracticalDermatology.com, PracticalDermatology.com, Product Launches and Updates, Allergan

Inside Spotlyte: Allergan's Digital Hub to Educate Consumers About Medical Aesthetic Treatments

Allergan has launched Spotlyte, described as an innovative digital hub of curated content that helps consumers discover how medical aesthetic treatments may fit into their routines. Spotlyte is t…

Read the full story

Wednesday, August 22, 2018 | PracticalDermatology.com, Research and Publications

New Guidelines Seek to Rein in Inappropriate Teen Plastic Surgeries

New teen plastic surgery guidelines call for age consideration, parental consent and other measures to improve upon the safety of these procedures. The guidelines are published in the September iss…

Read the full story

Sunday, August 05, 2018 | Personnel/Company News, PracticalDermatology.com

Evolus Resubmits BLA for DWP-450 Ahead of Schedule

Evolus has resubmitted its Biologics License Application (BLA) for its lead product candidate, DWP-450 (prabotulinumtoxinA), to the FDA. The resubmission follows the receipt of a Complete Resp…

Read the full story

Friday, August 03, 2018 | PracticalDermatology.com, Research and Publications, ASAPS

Leading Plastic Surgery Groups Warn on the Risks of Brazilian Butt Lifts

Leading plastic surgery organizations are issuing a loud warning call about the risks associated with the popular Brazilian Butt Lift. “[The] procedure … has resulted in a mortality ra…

Read the full story
Load More